<p>1. Multiple Sclerosis: clinical Features, Pathophysiology, Diagnosis, and Management<br>2. Neuttralizing Antibodies and Multiple Sclerosis inthe Era of Disease Modifying Treatments<br>3. Animal Models of Multiple Sclerosis<br>4. Neuroimaging of Multiple Sclerosis and Other Immune-Mediated Diseases of Central Nervous System: An Update<br>5. Role of IL-12/IL-23 in the Pathogenesis of Multiple Sclerosis<br>6. Acute Transverse Myelitis: Clinical Features, Pathophysiology, and Treatment Options<br>7. Remyelination in Multiple Sclerosis: A Mechanistic Look<br>8. The Way Forward With Vitamin D in Multiple Sclerosis<br>9. Autoimmune Encephalitis: Clinical Features, Pathophysiology, and Management<br>10. Immune Dysregulation in Epilepsy<br>11. Neurosarcoidosis: Clinical Features, Pathophysiology, and Management<br>12. Existing and Emerging Therapies for Multiple Sclerosis<br>13. Tumefactive Demyelination in Multiple Sclerosis: Clinical Presentation, Pathophysiology and Treatment Options<br>14. Pediatric Multiple Sclerosis<br>15. Acute Disseminated Encephalomyelitis: Clinical Presentation, Pathophysiology, Diagnosis, and Treatment<br>16. Neuromyelitis Optica Spectrum Disorders<br>17. Optic Neuritis: Clinical Manifestations, Pathophysiology, and Management<br>18. Ischemic Demyelination<br>19. Inflammatory Mechanisms in Ischemic Cerebrovascular Disease<br>20. Two-Pore Domain Potassium Channels (K2Ps) as Drug Targets in Neuroinflammation<br>21. Interferon Gamma Versus Beta-Interferon in Pathogenesis of Multiple Sclerosis: Battle of Two Interferons<br>22. Inflammatory Mediators in Obstructive Sleep Apnea<br>23. Central Nervous System Vasculitis<br>24. Role of Inflammatory Mechanisms in Guillain-Barre’ Syndrome<br>25. Roles of Macrophages and Astrocytes in Pathogenesis of Multiple Sclerosis<br>26. Blood-Brain Barrier Disruption During Neuroinflammation <br>27. Roles of Toll-Like Receptors in Pathophysiology of Alzheimer’s Disease and Multiple Sclerosis<br>28. Role of Neuroinflammation in the Pathophysiology of Traumatic Brain Injury<br>29. The Contribution of Extra Cranial Venous Drainage to Neuro-Inflammation in Multiple Sclerosis<br>30. Lymphatic Drainage of the CNS and Its Role in Neuroinflammation and Neurodegenerative Disease<br>31. A Complete Review on Epigenetic Biomarkers in MS</p>